MITCHELL RUNGE: Open Payments
NPI 1497231013 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 97 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $525 · 2025 $1,759
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $216 |
| Axsome Therapeutics, Inc. | 13 | $178 |
| Novo Nordisk Inc | 10 | $177 |
| Lilly USA, LLC | 8 | $158 |
| AstraZeneca Pharmaceuticals LP | 7 | $146 |
| Amgen Inc. | 8 | $145 |
| ABBVIE INC. | 7 | $136 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Eisai Inc. | 2 | $59 |
Products named: AIRSUPRA, Auvelity, NURTEC ODT, KISUNLA, LEQVIO, OTEZLA, ELIQUIS, EVENITY.
Industry payments across MO — which companies pay providers there.
